December 06, 2018
Rose
But antitrust experts say it's only possible for the Department of Justice to block the merger. DOJ approved the $70 billion deal in October. Meanwhile, CVS and Aetna are moving ahead with integration plans. Other industry news looks at CVS' new prescription drug-price plans and rising costs of Pitocin and Ketamine.
from Kaiser Health News https://ift.tt/2E3rPTK
December 06, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
KHN’s ‘What the Health?’: Georgia Turns the Senate Blue- As the Vulnerable Wait, Some Political Leaders’ Spouses Get Covid Vaccines
- Illinois, primer estado en ofrecer cobertura médica a adultos mayores indocumentados
- Do-It-Yourself Contact Tracing Is a ‘Last Resort’ in Communities Besieged by Covid
- Biden’s First Order of Business May Be to Undo Trump’s Policies, but It Won’t Be Easy
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment